Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Cyclin dependent kinase 5 (CDK5) regulates the circadian clock.

Brenna A, Olejniczak I, Chavan R, Ripperger JA, Langmesser S, Cameroni E, Hu Z, De Virgilio C, Dengjel J, Albrecht U.

Elife. 2019 Nov 5;8. pii: e50925. doi: 10.7554/eLife.50925. [Epub ahead of print]

2.

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.

Walls AC, Xiong X, Park YJ, Tortorici MA, Snijder J, Quispe J, Cameroni E, Gopal R, Dai M, Lanzavecchia A, Zambon M, Rey FA, Corti D, Veesler D.

Cell. 2019 Feb 21;176(5):1026-1039.e15. doi: 10.1016/j.cell.2018.12.028. Epub 2019 Jan 31.

PMID:
30712865
3.

Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset.

de Wit E, Feldmann F, Horne E, Okumura A, Cameroni E, Haddock E, Saturday G, Scott D, Gopal R, Zambon M, Corti D, Feldmann H.

Antiviral Res. 2019 Mar;163:70-74. doi: 10.1016/j.antiviral.2019.01.016. Epub 2019 Jan 24.

PMID:
30684561
4.

Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors.

Morgan SB, Holzer B, Hemmink JD, Salguero FJ, Schwartz JC, Agatic G, Cameroni E, Guarino B, Porter E, Rijal P, Townsend A, Charleston B, Corti D, Tchilian E.

Front Immunol. 2018 Apr 24;9:865. doi: 10.3389/fimmu.2018.00865. eCollection 2018.

5.

Characterization of a chimeric chemokine as a specific ligand for ACKR3.

Ameti R, Melgrati S, Radice E, Cameroni E, Hub E, Thelen S, Rot A, Thelen M.

J Leukoc Biol. 2018 Aug;104(2):391-400. doi: 10.1002/JLB.2MA1217-509R. Epub 2018 Mar 30.

6.

Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.

Pennini ME, De Marco A, Pelletier M, Bonnell J, Cvitkovic R, Beltramello M, Cameroni E, Bianchi S, Zatta F, Zhao W, Xiao X, Camara MM, DiGiandomenico A, Semenova E, Lanzavecchia A, Warrener P, Suzich J, Wang Q, Corti D, Stover CK.

Nat Commun. 2017 Dec 8;8(1):1991. doi: 10.1038/s41467-017-02223-7.

7.

A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.

Wang J, Bardelli M, Espinosa DA, Pedotti M, Ng TS, Bianchi S, Simonelli L, Lim EXY, Foglierini M, Zatta F, Jaconi S, Beltramello M, Cameroni E, Fibriansah G, Shi J, Barca T, Pagani I, Rubio A, Broccoli V, Vicenzi E, Graham V, Pullan S, Dowall S, Hewson R, Jurt S, Zerbe O, Stettler K, Lanzavecchia A, Sallusto F, Cavalli A, Harris E, Lok SM, Varani L, Corti D.

Cell. 2017 Sep 21;171(1):229-241.e15. doi: 10.1016/j.cell.2017.09.002.

8.

Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8384-8389. doi: 10.1073/pnas.1704984114. Epub 2017 Jul 17.

9.

The yeast protein kinase Sch9 adjusts V-ATPase assembly/disassembly to control pH homeostasis and longevity in response to glucose availability.

Wilms T, Swinnen E, Eskes E, Dolz-Edo L, Uwineza A, Van Essche R, Rosseels J, Zabrocki P, Cameroni E, Franssens V, De Virgilio C, Smits GJ, Winderickx J.

PLoS Genet. 2017 Jun 12;13(6):e1006835. doi: 10.1371/journal.pgen.1006835. eCollection 2017 Jun.

10.

Tackling influenza with broadly neutralizing antibodies.

Corti D, Cameroni E, Guarino B, Kallewaard NL, Zhu Q, Lanzavecchia A.

Curr Opin Virol. 2017 Jun;24:60-69. doi: 10.1016/j.coviro.2017.03.002. Epub 2017 May 18. Review.

PMID:
28527859
11.

Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4.

Cohen TS, Pelletier M, Cheng L, Pennini ME, Bonnell J, Cvitkovic R, Chang CS, Xiao X, Cameroni E, Corti D, Semenova E, Warrener P, Sellman BR, Suzich J, Wang Q, Stover CK.

JCI Insight. 2017 May 4;2(9). pii: 92774. doi: 10.1172/jci.insight.92774. eCollection 2017 May 4.

12.

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.

Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D.

Science. 2016 Aug 19;353(6301):823-6. doi: 10.1126/science.aaf8505. Epub 2016 Jul 14.

13.

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.

Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ.

Science. 2016 Mar 18;351(6279):1339-42. doi: 10.1126/science.aad5224. Epub 2016 Feb 25.

14.

Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice.

Brennecke P, Arlt MJ, Muff R, Campanile C, Gvozdenovic A, Husmann K, Holzwarth N, Cameroni E, Ehrensperger F, Thelen M, Born W, Fuchs B.

PLoS One. 2013 Sep 10;8(9):e74045. doi: 10.1371/journal.pone.0074045. eCollection 2013.

15.

CCR2 acts as scavenger for CCL2 during monocyte chemotaxis.

Volpe S, Cameroni E, Moepps B, Thelen S, Apuzzo T, Thelen M.

PLoS One. 2012;7(5):e37208. doi: 10.1371/journal.pone.0037208. Epub 2012 May 17.

16.

On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations.

Cameroni E, Stettler K, Suter B.

Cell Div. 2010 Sep 15;5:24. doi: 10.1186/1747-1028-5-24.

17.

Initiation of the TORC1-regulated G0 program requires Igo1/2, which license specific mRNAs to evade degradation via the 5'-3' mRNA decay pathway.

Talarek N, Cameroni E, Jaquenoud M, Luo X, Bontron S, Lippman S, Devgan G, Snyder M, Broach JR, De Virgilio C.

Mol Cell. 2010 May 14;38(3):345-55. doi: 10.1016/j.molcel.2010.02.039.

18.

CXCR7 functions as a scavenger for CXCL12 and CXCL11.

Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, Thelen M.

PLoS One. 2010 Feb 11;5(2):e9175. doi: 10.1371/journal.pone.0009175.

19.

Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs.

Mok J, Kim PM, Lam HY, Piccirillo S, Zhou X, Jeschke GR, Sheridan DL, Parker SA, Desai V, Jwa M, Cameroni E, Niu H, Good M, Remenyi A, Ma JL, Sheu YJ, Sassi HE, Sopko R, Chan CS, De Virgilio C, Hollingsworth NM, Lim WA, Stern DF, Stillman B, Andrews BJ, Gerstein MB, Snyder M, Turk BE.

Sci Signal. 2010 Feb 16;3(109):ra12. doi: 10.1126/scisignal.2000482.

20.

Caffeine extends yeast lifespan by targeting TORC1.

Wanke V, Cameroni E, Uotila A, Piccolis M, Urban J, Loewith R, De Virgilio C.

Mol Microbiol. 2008 Jul;69(1):277-85. doi: 10.1111/j.1365-2958.2008.06292.x. Epub 2008 May 26.

21.

Control of cellular physiology by TM9 proteins in yeast and Dictyostelium.

Froquet R, Cherix N, Birke R, Benghezal M, Cameroni E, Letourneur F, Mösch HU, De Virgilio C, Cosson P.

J Biol Chem. 2008 Mar 14;283(11):6764-72. doi: 10.1074/jbc.M704484200. Epub 2008 Jan 3.

22.

The evolutionary conserved BER1 gene is involved in microtubule stability in yeast.

Fiechter V, Cameroni E, Cerutti L, De Virgilio C, Barral Y, Fankhauser C.

Curr Genet. 2008 Feb;53(2):107-15. Epub 2007 Dec 7.

PMID:
18064466
23.

Membrane stress is coupled to a rapid translational control of gene expression in chlorpromazine-treated cells.

De Filippi L, Fournier M, Cameroni E, Linder P, De Virgilio C, Foti M, Deloche O.

Curr Genet. 2007 Sep;52(3-4):171-85. Epub 2007 Aug 21.

PMID:
17710403
24.

Modulation of Ubc4p/Ubc5p-mediated stress responses by the RING-finger-dependent ubiquitin-protein ligase Not4p in Saccharomyces cerevisiae.

Mulder KW, Inagaki A, Cameroni E, Mousson F, Winkler GS, De Virgilio C, Collart MA, Timmers HT.

Genetics. 2007 May;176(1):181-92.

25.

Phosphatidylinositol 4-phosphate is required for translation initiation in Saccharomyces cerevisiae.

Cameroni E, De Virgilio C, Deloche O.

J Biol Chem. 2006 Dec 15;281(50):38139-49. Epub 2006 Sep 27.

26.

Rim15 and the crossroads of nutrient signalling pathways in Saccharomyces cerevisiae.

Swinnen E, Wanke V, Roosen J, Smets B, Dubouloz F, Pedruzzi I, Cameroni E, De Virgilio C, Winderickx J.

Cell Div. 2006 Apr 3;1:3.

27.

Regulation of G0 entry by the Pho80-Pho85 cyclin-CDK complex.

Wanke V, Pedruzzi I, Cameroni E, Dubouloz F, De Virgilio C.

EMBO J. 2005 Dec 21;24(24):4271-8. Epub 2005 Nov 24.

28.

The Bud14p-Glc7p complex functions as a cortical regulator of dynein in budding yeast.

Knaus M, Cameroni E, Pedruzzi I, Tatchell K, De Virgilio C, Peter M.

EMBO J. 2005 Sep 7;24(17):3000-11. Epub 2005 Aug 18.

29.

The TOR and EGO protein complexes orchestrate microautophagy in yeast.

Dubouloz F, Deloche O, Wanke V, Cameroni E, De Virgilio C.

Mol Cell. 2005 Jul 1;19(1):15-26.

30.

PKA and Sch9 control a molecular switch important for the proper adaptation to nutrient availability.

Roosen J, Engelen K, Marchal K, Mathys J, Griffioen G, Cameroni E, Thevelein JM, De Virgilio C, De Moor B, Winderickx J.

Mol Microbiol. 2005 Feb;55(3):862-80.

31.

The Ccr4-Not complex independently controls both Msn2-dependent transcriptional activation--via a newly identified Glc7/Bud14 type I protein phosphatase module--and TFIID promoter distribution.

Lenssen E, James N, Pedruzzi I, Dubouloz F, Cameroni E, Bisig R, Maillet L, Werner M, Roosen J, Petrovic K, Winderickx J, Collart MA, De Virgilio C.

Mol Cell Biol. 2005 Jan;25(1):488-98.

32.

The novel yeast PAS kinase Rim 15 orchestrates G0-associated antioxidant defense mechanisms.

Cameroni E, Hulo N, Roosen J, Winderickx J, De Virgilio C.

Cell Cycle. 2004 Apr;3(4):462-8.

PMID:
15300954
33.

TOR and PKA signaling pathways converge on the protein kinase Rim15 to control entry into G0.

Pedruzzi I, Dubouloz F, Cameroni E, Wanke V, Roosen J, Winderickx J, De Virgilio C.

Mol Cell. 2003 Dec;12(6):1607-13.

34.

Antianginal and haemodynamic effects of a new beta-blocking agent, SD 1601.

Radice M, Folli G, Tavecchia A, Mariotti G, Cameroni E.

Arzneimittelforschung. 1978;28(11):2160-3.

PMID:
40567
35.

[Pathological behavior of the systolic period in angina patients independent of ischemic crisis].

Folli G, Radice M, Tavecchia S, Cameroni E, Mariotti G.

Boll Soc Ital Cardiol. 1973;18(7):597-601. Italian. No abstract available.

PMID:
4807145
36.

[Polycardiographic evaluation of the modifications in the heart inotropism induced by propranolol and practolol].

Giani P, Cameroni E, Fantola E, Folli G, Radice M.

Boll Soc Ital Cardiol. 1972;17(10):858-64. Italian. No abstract available.

PMID:
4681408

Supplemental Content

Loading ...
Support Center